About admin-araim-2015

This author has not yet filled in any details.
So far admin-araim-2015 has created 6 blog entries.

Araim Pharmaceuticals’ ARA 290 significantly improves islet cell function following islet cell transplantation in a model of Type 1 diabetes

Araim Pharmaceuticals’ ARA 290 significantly improves islet cell function following islet cell transplantation in a model of Type 1 diabetes

December 23rd, 2015|Press Release|

December 17, 2014 Molecular Medicine Issues 20th Anniversary Edition. Journal Focuses on the legacy and impact of Anthony Cerami’s groundbreaking work on diabetes

Molecular Medicine Issues 20th Anniversary Edition. Journal Focuses on the legacy and impact of Anthony Cerami’s groundbreaking work on diabetes

December 17th, 2014|Press Release|

New Study Published In Molecular Medicine Reports That Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes

New Study Published In Molecular Medicine Reports That Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes

December 15th, 2014|Uncategorized|

Araim Pharmaceuticals Given FDA Fast Track Designation to ARA 290 for the Treatment of Sarcoidosis (Dutch Version)

Araim Pharmaceuticals Given FDA Fast Track Designation to ARA 290 for the Treatment of Sarcoidosis (Dutch Version)

December 1st, 2014|Press Release|

Araim Pharmaceuticals Given FDA Fast Track Designation to ARA 290 for the Treatment of Sarcoidosis-associated Small Fiber Neuropathy

Araim Pharmaceuticals Given FDA Fast Track Designation to ARA 290 for the Treatment of Sarcoidosis-associated Small Fiber Neuropathy

October 28th, 2014|Press Release|

Araim Pharmaceuticals’ ARA 290, a Peptide Engineered to Activate Innate Repair, Receives Orphan Drug Designation from the European Commission

Araim Pharmaceuticals’ ARA 290, a Peptide Engineered to Activate Innate Repair, Receives Orphan Drug Designation from the European Commission

October 10th, 2013|Press Release|